Journal of Thrombosis and Thrombolysis

, Volume 11, Issue 2, pp 151–154

Clinical Application of Procedural Platelet Monitoring during Percutaneous Coronary Intervention among Patients at Increased Bleeding Risk

Authors

  • Debabrata Mukherjee
    • Department of CardiologyUniversity of Michigan
    • Clinic Foundation
  • Derek P. Chew
    • Department of CardiologyUniversity of Michigan
  • Mark Robbins
    • Department of CardiologyUniversity of Michigan
  • Jay S. Yadav
    • Department of CardiologyUniversity of Michigan
  • Russell E. Raymond
    • Department of CardiologyUniversity of Michigan
  • David J. Moliterno
    • Department of CardiologyUniversity of Michigan
Article

DOI: 10.1023/A:1011228817265

Cite this article as:
Mukherjee, D., Chew, D.P., Robbins, M. et al. J Thromb Thrombolysis (2001) 11: 151. doi:10.1023/A:1011228817265

Abstract

The goal of platelet function testing in the catheterization laboratory is to provide information about the platelet contributions to the risk of thrombotic or hemorrhagic events and optimization of anti-platelet therapy for percutaneous interventions. We present several illustrative cases in which platelet monitoring with the Rapid Platelet Function Assay (RPFATM, Accumetrics) was used to guide dosing of a glycoprotein (GP) IIb/IIIa inhibitor for coronary and peripheral intervention among patients at increased bleeding risk.

coronary artery diseasepercutaneous interventionplateletabciximabGP IIb/IIIa inhibitor
Download to read the full article text

Copyright information

© Kluwer Academic Publishers 2001